New hemp-derived CBD regulations in Colorado

The Colorado Department of Public Health and Environment (CDPHE) has finalized state testing requirements for hemp. The new regulations take effect on October 1 and include all hemp-derived goods intended for human consumption, including hemp-infused CBD products.

“We don’t want to burden the industry,” Jeff Lawrence, CDPHE director of environmental health and sustainability, told Westword. “But what we’ve learned is that there are things in hemp products that we obviously need to be considerate of. Since the inception of hemp, Colorado has been a leader in this industry. This will provide some better guidance.”

Testing will screen for things like pesticides, heavy metals, and residual solvents.

Hemp-infused products like foods, drinks, nutritional supplements, cosmetics, and pet products will be subject to the new testing requirements. Industrial hemp products like textiles, fuel, and building materials, are excluded from the testing requirements. Hemp-derived smokable products, including those with modified cannabinoids like Delta-8 THC, are also excluded from the new regulations.

“Ultimately, this is a public-health issue. In 2018, when, statutorily, these products were allowed, we said it would be treated like every other food and dietary supplement requirement,” Lawrence said.

DEA-approved medical marijuana research facility coming to Denver

A Denver-based marijuana research and cultivation firm received approval from the Drug Enforcement Agency (DEA) to begin federally-approved medical marijuana studies.

The research license will allow MedPharm to study all of the molecules known to be made by the cannabis plant—more than 400 so far. The company will also be studying the interaction between phytocannabinoids and different brain cells.

“Access to the diversity of chemicals produced by cannabis has never been greater, and we are excited to unlock the medical potential of these compounds,” said Dr. Tyrell Towle, MedPharm’s director of chemistry and research.

Although MedPharm is licensed to grow medical marijuana for research purposes at the city and state levels, they’re still waiting on the DEA to approve federal licensing. That means that the company won’t be using its own marijuana for research. Currently, the University of Mississippi is the only federally licensed medical marijuana research supplier.

Colorado Cannabis Business Office focuses on social equity

Governor Jared Polis announced the creation of a new office aimed at supporting cannabis businesses and promoting social equity.

The Cannabis Business Office (CBO) was created as part of a bill passed earlier this year. $4 million was set aside for the program for the 2022-’23 fiscal year from the state Marijuana Tax Cash Fund.

According to the CBO, the office will:

“This office will offer tools like technical help and improve access to money for businesses. Where the federal government has fallen behind, Colorado will lead. Colorado is, and always has been, the best place to live, work, grow and sell cannabis,” Polis said in a press release.

It’s no secret that Mountain High Select Suckers are the best CBD lollipops on the market. Our broad-spectrum hemp-infused CBD lollipops come in a variety of flavors and produce a moderate effect perfect for beginners or experienced edible connoisseurs.

Check out some of our recent reviews:

Our Straw-Nana lollipop was rated well by Weed Republic for its quality CBD, low dosage, and unique and incredible flavor.

“This unique, one-of-a-kind CBD lollipop is not only an amazing flavor combination but also features bits of both strawberry and banana on the surface of the lollipop! This flavor-packed candy is infused with only 6mg of CBD, which makes it a great option for adults of almost any age to use.”

Incredible Edibles recommended Mountain High Select for newbies to cannabis edibles. “If you’re just starting out with CBD lollipops, this is a good option to start with as each lollipop comes with only 6 mg of CBD. They’re also economically priced.”

Remedy Journey rated both our Mountain High Select CBD lollipops and our THC & CBD-infused Mountain High Suckers as having the best flavor selection of any cannabis-infused lollipop.

Mountain High Select is “one of the oldest names in the cannabis industry. The team believes in keeping everything simple yet powerful and effective,” said Ask Growers. “What’s more special is that the products come in a wide range of flavors, aromas, and uniquely crafted delicacies. The experienced users love indulging and stocking up on most of the products from this brand.”

CBD Nerds rated Mountain High Suckers as one of the tastiest lollipops of 2021. Mountain High Select Suckers “may just be the only brand out there that specializes solely in CBD lollipops. For this reason, we consider them experts when it comes to developing and producing a quality CBD lollipop. This expertise can be seen in the variety of flavors that they offer, a variety that is unmatched by any other CBD brand on our list.”

If you’re looking for the best CBD suckers with the widest range of flavors and broad-spectrum cannabinoids, look no further than Mountain High Select!
 
Shop our CBD Suckers Today »

 

The EU’s highest court has ruled that CBD is not a narcotic because “it does not appear to have any psychotropic effect or any harmful effect on human health.”

The ruling comes as the result of a lawsuit in France against a company that makes CBD oil from whole hemp plants. In France, only the fiber and seeds of hemp plants containing less than 0.2% THC can be used commercially.

The EU court ruled that France’s law banning the use of whole plant hemp-derived CBD went against the EU’s law on the free movement of goods.

“The national court must assess available scientific data in order to make sure that the real risk to public health alleged does not appear to be based on purely hypothetical considerations,” the court ruled.

“A decision to prohibit the marketing of CBD, which indeed constitutes the most restrictive obstacle to trade in products lawfully manufactured and marketed in other [EU] member states, can be adopted only if that risk appears sufficiently established,” the court wrote.

While individual countries can ban the free movement of goods for things like narcotic drugs, the court’s ruling means that those rules don’t apply to CBD.

Plus, as the court cited in their ruling, France has not banned synthetic CBD, which has the same properties as plant-derived CBD—making the prohibition of plant-derived CBD inconsistent.

The court’s decision could potentially open up the legal CBD market in Europe. Many CBD products currently exist in the grey market under rules that allow cannabis to be sold for agricultural purposes. Regulations about cannabis edibles and CBD have been stalled and in limbo, but the court’s decision could reopen a pathway to selling CBD edibles as food in Europe.

“With today’s ruling, CBD companies can expect a clearer route to achieving compliance across the EU. The harmonization of cannabinoid regulations could finally become a reality,” wrote the UK-based Association for the Cannabinoid Industry.

 

Senate Majority Leader Mitch McConnell and other members of Congress are urging the Food and Drug Administration (FDA) to speed up its guidance on hemp-derived CBD products. Specifically, Congress wants the FDA to issue formal “enforcement discretion” regarding CBD.

Hemp was legalized last year thanks to the 2018 Farm Bill, which made CBD legal as well. However, without guidance from the FDA, hemp and CBD are in a regulatory gray area. Lawmakers say that the FDA’s current approach to CBD has “created significant regulatory and legal uncertainty for participants in this quickly evolving industry.”

Currently, the FDA prohibits adding CBD to food or drinks marketed beyond a single state or to be added to food as a dietary supplement. Because of the regulatory confusion, some local governments have insisted that CBD is illegal in their state.

“Given the widespread availability of CBD products, growing consumer demand, and the expected surge in the hemp farming in the near future, it’s critical that FDA act quickly to provide legal and regulatory clarity to support this new economic opportunity,” lawmakers wrote.

The FDA has said it could take years to finalize CBD regulations. Congress isn’t waiting, and the US Senate Appropriations Subcommittee on Agriculture is working on guidelines to submit to the FDA. According to U.S. Hemp Rountable, Congress is working on rules that would require the FDA to:

Lawmakers wrote that they appreciate that the FDA has pursued “enforcement actions against the worst offenders,” but that “it can do so while eliminating regulatory uncertainty for farmers, retailers, and consumers.”

“Without a formal enforcement discretion policy, anyone participating in the growing marketplace for legal hemp-derived products will continue to face significant legal and regulatory uncertainty.”

McConnell, who has been supportive of the hemp industry, does not support ending marijuana prohibition. Asked to comment of legalizing hemp but not cannabis, McConnell said that hemp is “a different plant. It has an illicit cousin which I choose not to embrace.”